title: Successful Desensitization to Irinotecan After Severe Hypersensitivity Reaction.
authors.affiliation: Allergy Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.|Instituto de Investigación Sanitaria Aragón (IIS Aragón), Spain.
authors.forename: J L
authors.initials: JL
authors.lastname: Cubero
authors.affiliation: Instituto de Investigación Sanitaria Aragón (IIS Aragón), Spain.|Oncology Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Escudero
authors.affiliation: Instituto de Investigación Sanitaria Aragón (IIS Aragón), Spain.|Oncology Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Yubero
authors.affiliation: Intensive Care Unit, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Millán
authors.affiliation: Pharmacy Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.
authors.forename: M A
authors.initials: MA
authors.lastname: Sagredo
authors.affiliation: Allergy Department, University Hospital Lozano Blesa of Zaragoza, Zaragoza, Spain.|Instituto de Investigación Sanitaria Aragón (IIS Aragón), Spain.
authors.forename: C
authors.initials: C
authors.lastname: Colás
mesh_terms: D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods; D004342:Drug Hypersensitivity / Q000276:immunology*; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged
chemical_list: D000077146:Irinotecan; D002166:Camptothecin